PAS-19-316 - Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
NOT-AG-22-011 |
NIA, NINDS |
Jan 24, 2022 |
May 12, 2026 |
R43/R44 |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research |
NOT-CA-22-037 |
NCI, NHLBI, NIA, NIDA, NIMH, NINR, OBSSR |
Jan 27, 2022 |
Mar 9, 2024 |
R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33 |
An official website of the United States government
